Guifu Dai
Inventor
Stats
- 3 US patents issued
- 6 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 3 US Patents Issued
- 6 US Applications Filed
- 0 Total Citation Count
- Sep 2, 2020 Most Recent Filing
- Oct 19, 2011 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| Zhengzho University | 1
| 2013
|
| ZHENGZHOU UNIVERSITY | 2
1 2 2 | 2011
2012 2013 2016 |
Inventor Addresses
| Address | Duration |
|---|---|
| Henan, CN | Jul 03, 14 - Jul 03, 14 |
| Zhengzhou City, CN | Feb 19, 15 - Sep 29, 16 |
| Zhengzhou, CN | Sep 12, 13 - Jun 28, 22 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 5 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 2 |
| C07D: | HETEROCYCLIC COMPOUNDS | 6 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 11369584 | 2022 | Andrographolide derivatives and method of using the same for treatment or prevention of fibrosis | 0 |
| 11279695 | 2022 | Andrographolide compound and method for treatment or prevention of fibrotic disease using the same | 0 |
| 2021/0047,307 | 2021 | ANDROGRAPHOLIDE COMPOUND AND METHOD FOR TREATMENT OR PREVENTION OF FIBROTIC DISEASE USING THE SAME | 0 |
| 2020/0030,280 | 2020 | ANDROGRAPHOLIDE DERIVATIVES AND METHOD OF USING THE SAME FOR TREATMENT OR PREVENTION OF FIBROSIS | 0 |
| 9636324 | 2017 | Use of 15-benzylidence-14-deoxy-11, 12 -dehyroandrographolide derivative in manufacture of medicaments for protecting liver and anti-hepatitis C virus | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.